Table 4:

Relationship between study characteristics and beneficial outcomes

	Absolute Risk Difference (%)	Odds Ratio (95% CI)
Funding
Funded	−0.02	0.91 (0.28–2.99)
Not Funded	Ref	Ref
Study Design
Experimental	−0.09	0.60 (0.16–2.21)
Non-experimental	Ref	Ref
Sample Size
4–93 (Quartile 1)	Ref	Ref
100–264 (Quartile 2)	−0.07	0.66 (0.19–2.34)
278–1295 (Quartile 3)	−0.13	0.49 (0.15–1.55)
1508–4 352 082 (Quartile 4)	0.12	0.53 (0.15–1.91)
Continuum Level
Risk Assessment	−0.14	0.49 (0.08–2.94)
Prevention	Ref	Ref
Detection	−0.12	0.52 (0.12–2.20)
Diagnosis	−77**	0.01 (0.001–0.17)
Treatment	−39*	0.16 (0.03–0.91)
HIT Intervention Focus
Patient	−31*	0.19 (0.04–0.86)
Provider	Ref	Ref
Both	−0.07	0.70 (0.05–9.62)
Study Outcomes
Behavior Change	−41**	0.14 (0.03–0.57)
Decision Making	+27*	5.80 (1.15–29.38)
Psychosocial	−30	0.25 (0.03–2.47)

*P < .05.

**P < .01.